![John Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Zhang
Direttore Tecnico/Scientifico/R&S presso IMMUNE PHARMACEUTICALS, INC.
Posizioni attive di John Zhang
Società | Posizione | Inizio | Fine |
---|---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 11/12/2017 | - |
Storia della carriera di John Zhang
Precedenti posizioni note di John Zhang
Società | Posizione | Inizio | Fine |
---|---|---|---|
Pharmacopeia LLC
![]() Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 18/12/2009 | - |
ENZON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
EnzymeRx LLC
![]() EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Direttore Tecnico/Scientifico/R&S | 18/12/2009 | - |
Formazione di John Zhang
Guangzhou University | Doctorate Degree |
University of California, Los Angeles | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Cina | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ENZON PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 3 |
---|---|
EnzymeRx LLC
![]() EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Health Technology |
Pharmacopeia LLC
![]() Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Immune Pharmaceuticals, Inc.
![]() Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
- Borsa valori
- Insiders
- John Zhang
- Esperienza